| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy does not update its risk assessment when its services change, for example when introducing a weight management service. Its overarching risk assessment although detailed does not contain risks for specific treatments and/or medicines such as for aesthetic products and weight loss medicines. And although its risk assessment has actions to take to minimise risk, not all of these are implemented into the pharmacy's procedures, for example implementing a clinical audit schedule and completing spot checks of prescribers' registration status. |
• Produce and update all risk assessments for all services delivered from the pharmacy. This will include the following services: Weight management, blood testing (in partnership with medichecks), erectile dysfunction, male hair loss, female hair loss, period delay, period pain, contraception, female facial hair removal, as well as menopause and HRT support services. New services in addition to weight management will not be offered to patients until risk assessments have been completed. |
02/09/2025 | 25/09/2025 |
| 1.2 | The pharmacy does not complete regular, documented audits to ensure its processes are robust and team members are following them. For example, to show prescribers providing aesthetic services have face-to-face consultations with people. And it doesn't record all its interventions with prescribers to learn from them. This means the pharmacy cannot proactively monitor the quality of its services. |
• Develop and implement a comprehensive audit plan and schedule to regularly review all services provided from the pharmacy. This will operate across a 12 month schedule and reviewed annually. |
02/09/2025 | 25/09/2025 |
| 1.1 | The pharmacy does not have specific guidance about the aesthetic products it supplies. For example it does not have copies of aesthetic treatment protocols available for the pharmacy team to refer to when checking maximum quantities and frequency of supplies. |
• Training and educational resources exist for these products but need translating into pharmacy specific guidance documents. We will create user/treatment guides for all treatments supplied from the pharmacy that can be accessed by all members of the pharmacy team. These will also act as training materials for any future pharmacists and pharmacy team members working from the premises. |
02/09/2025 | 25/09/2025 |
| 4.2 | The pharmacy dispenses private prescriptions for aesthetic products and medicines which are not legally valid. The address of the prescriber is recorded incorrectly as that of the pharmacy premises. These prescriptions do not have directions for use. And although the products have a treatment protocol included in the pack, it makes it difficult for the pharmacy to know how the prescriber intends its use. And for the patient to understand how to use any treatment they may take home. |
• Working with electronic private prescription partner (SignatureRx) to find a solution to way prescriptions arrive at the pharmacy and display all the correct address information in a format compliant with regulations. This activity has been started already. We will also explore other solutions if this is not possible through our current provider. |
02/09/2025 | 25/09/2025 |
Pharmacy inspections
Inspection reports and learning from inspections